Brand-name biologic drug companies would usually have to keep some biosimilar patent lawsuits smaller. The bill caps how many patents they can press at once, with some exceptions. That could affect how fast lower-cost biosimilars can fight patent disputes and try to enter the market.
Modern Action explains what the legislation does, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
Affordable Prescriptions for Patients Act is a House bill awaiting final action. The latest recorded action: Held at the desk.
Latest action on S. 1041: Held at the desk.
Who this affects: This bill mainly affects companies that make brand-name biologic drugs and companies trying to sell biosimilars. It could also matter to patients, insurers, and government health programs if it changes how fast lower-cost competitors can get through patent fights and reach the market.
Why this matters: Biologic drugs can be very expensive, so patent fights that delay biosimilars can affect what people and health plans pay. This bill tries to narrow some of those fights by limiting how many patents a brand company can bring at once in one case. That could make some lawsuits less sprawling and more predictable. But judges can still expand the case, and some patents are not covered by the cap, so the real effect on prices and access is still uncertain.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
Officially: Affordable Prescriptions for Patients Act
Brand-name biologic drug companies would usually have to keep some biosimilar patent lawsuits smaller. The bill caps how many patents they can press at once, with some exceptions. That could affect how fast lower-cost biosimilars can fight patent disputes and try to enter the market.
Use this page to support, oppose, or ask Congress to amend S.1041. Modern Action explains what the bill does, helps identify the right senators or representative, and drafts a bill-specific message you can edit and send.
Where it stands
Passed Senate. Now before the House.
This is the moment to act.
↓ Why your message matters here
This bill passed the Senate and is now before the House — this is the moment to act.
Enter your ZIP to see how your senators and member of Congress have voted, sponsored, or spoken on this bill.
The debate
Where this bill is in the process
Introduced
Introduced in Senate
Senate Committee
Under Senate committee consideration
Senate Floor Vote
Voted on by Senate
Passed Senate
Approved by Senate
House Review
Sent to House for consideration
Latest: Message on Senate action sent to the House. (7/21/2026)
Passed Both Chambers
Approved by both House and Senate
Signed into Law
Signed by the President
For more detail
Choose one clear position: support, oppose, or amend. Then pick any reasons or personal context you want included. Modern Action uses that input and the bill context to draft a message you can edit and send.
Congressional offices prioritize messages from their own constituents. Modern Action uses your address to route the drafted message to your House representative when that is the most relevant target for this bill.
The draft includes the bill number, your position, the reasons you selected, any personal context you added, and a direct ask such as voting yes, voting no, cosponsoring, opposing, or seeking changes. You stay in control because you can edit the message before sending.
This page gives you an opportunity to support, oppose, or ask for changes to Affordable Prescriptions for Patients Act, then contact the elected officials who can act. Modern Action drafts the message from your position and the reasons you select.
Modern Action keeps the action tied to the bill itself: what it does, where it is in the process (desk), which office can still act, and what ask belongs in the message.
You are not starting from a blank form. Modern Action drafts the message around S.1041, your stance, and the reasons you choose, then lets you edit and send when ready.
